West Pharmaceutical (WST) announced the appointment of Robert McMahon as the company’s new CFO, effective August 4. McMahon will succeed Bernard Birkett, CFO, who announced his intention to retire earlier this year. Birkett will assume the role of senior advisor to the CEO through the end of the year to ensure a transition. McMahon has been CFO of Agilent (A) since 2018.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WST:
- West Pharmaceutical initiated with an Equal Weight at Barclays
- WST Lawsuit Alert! Class Action Lawsuit Against West Pharmaceutical Services, Inc.
- Buy Rating for West Pharmaceutical Services: Anticipated Growth and Strategic Initiatives Drive Positive Outlook
- Citi opens ‘upside 90-day short-term view’ on West Pharmaceutical